# Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

> **NCT01412047** · — · COMPLETED · sponsor: **Alexion Pharmaceuticals, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria
- PNH

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01412047
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-06-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01412047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01412047, "Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01412047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*